Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Autoimmune Disorders

  Free Subscription


27.08.2018

2 Acta Neurol Scand
5 BMC Neurol
1 Diabet Med
1 J Autoimmun
1 J Neuroimmunol
1 J Neurol
1 Lancet Neurol
2 Mult Scler
1 Neurol Clin Pract
2 Neurology


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Acta Neurol Scand

  1. HAGHIGHI S, Forsmark S, Carlsson A, Nilsson MKL, et al
    Open study with (-)-OSU6162 in multiple sclerosis-related fatigue.
    Acta Neurol Scand. 2018 Aug 22. doi: 10.1111/ane.13007.
    PubMed     Text format     Abstract available

  2. SHU Y, Chang Y, Wu H, Li J, et al
    Serum cystatin C and anti-N-methyl-D-aspartate receptor encephalitis.
    Acta Neurol Scand. 2018;137:515-522.
    PubMed     Text format     Abstract available


    BMC Neurol

  3. TRABOULSEE A, Li DKB, Cascione M, Fang J, et al
    Predictive value of early magnetic resonance imaging measures is differentially affected by the dose of interferon beta-1a given subcutaneously three times a week: an exploratory analysis of the PRISMS study.
    BMC Neurol. 2018;18:68.
    PubMed     Text format     Abstract available

  4. KOTTERBA S, Neusser T, Norenberg C, Bussfeld P, et al
    Sleep quality, daytime sleepiness, fatigue, and quality of life in patients with multiple sclerosis treated with interferon beta-1b: results from a prospective observational cohort study.
    BMC Neurol. 2018;18:123.
    PubMed     Text format     Abstract available

  5. SUNTER G, Enver EO, Akbarzade A, Turan S, et al
    Acquired modification of sphingosine-1-phosphate lyase activity is not related to adrenal insufficiency.
    BMC Neurol. 2018;18:48.
    PubMed     Text format     Abstract available

  6. JIAO Y, Cui L, Zhang W, Zhang C, et al
    Dose effects of mycophenolate mofetil in Chinese patients with neuromyelitis optica spectrum disorders: a case series study.
    BMC Neurol. 2018;18:47.
    PubMed     Text format     Abstract available

  7. PETERS JE, Gupta V, Saeed IT, Offiah C, et al
    Severe localised granulomatosis with polyangiitis (Wegener's granulomatosis) manifesting with extensive cranial nerve palsies and cranial diabetes insipidus: a case report and literature review.
    BMC Neurol. 2018;18:59.
    PubMed     Text format     Abstract available


    Diabet Med

  8. AKTURK HK
    Management of Type 1 diabetes should be different from Type 2 diabetes at hospital admission.
    Diabet Med. 2018 Mar 5. doi: 10.1111/dme.13614.
    PubMed     Text format     Abstract available


    J Autoimmun

  9. WOHLERS I, Bertram L, Lill CM
    Evidence for a potential role of miR-1908-5p and miR-3614-5p in autoimmune disease risk using integrative bioinformatics.
    J Autoimmun. 2018 Aug 21. pii: S0896-8411(18)30119.
    PubMed     Text format     Abstract available


    J Neuroimmunol

  10. MORIGUCHI K, Miyamoto K, Fukumoto Y, Kusunoki S, et al
    4-Aminopyridine ameliorates relapsing remitting experimental autoimmune encephalomyelitis in SJL/J mice.
    J Neuroimmunol. 2018;323:131-135.
    PubMed     Text format     Abstract available


    J Neurol

  11. KANEKO A, Kaneko J, Tominaga N, Kanazawa N, et al
    Pitfalls in clinical diagnosis of anti-NMDA receptor encephalitis.
    J Neurol. 2018;265:586-596.
    PubMed     Text format     Abstract available


    Lancet Neurol

  12. TRAPP BD, Vignos M, Dudman J, Chang A, et al
    Cortical neuronal densities and cerebral white matter demyelination in multiple sclerosis: a retrospective study.
    Lancet Neurol. 2018 Aug 21. pii: S1474-4422(18)30245.
    PubMed     Text format     Abstract available


    Mult Scler

  13. BOVE R, Bevan C, Crabtree E, Zhao C, et al
    Toward a low-cost, in-home, telemedicine-enabled assessment of disability in multiple sclerosis.
    Mult Scler. 2018 Aug 24:1352458518793527. doi: 10.1177/1352458518793527.
    PubMed     Text format     Abstract available

  14. NICHOLAS RS, Han E, Raffel J, Chataway J, et al
    Over three decades study populations in progressive multiple sclerosis have become older and more disabled, but have lower on-trial progression rates: A systematic review and meta-analysis of 43 randomised placebo-controlled trials.
    Mult Scler. 2018 Aug 24:1352458518794063. doi: 10.1177/1352458518794063.
    PubMed     Text format     Abstract available


    Neurol Clin Pract

  15. KAAS B, Zeiler SR, Bahouth MN, Llinas RH, et al
    Autoimmune limbic encephalitis in association with acute stroke.
    Neurol Clin Pract. 2018;8:349-351.
    PubMed     Text format    


    Neurology

  16. MIDAGLIA L, Gratacos M, Caronna E, Raguer N, et al
    Myasthenia gravis following alemtuzumab therapy for multiple sclerosis.
    Neurology. 2018 Aug 24. pii: WNL.0000000000006251.
    PubMed     Text format    

  17. RUDANT J, Dupont A, Mikaeloff Y, Bolgert F, et al
    Surgery and risk of Guillain-Barre syndrome: A French nationwide epidemiologic study.
    Neurology. 2018 Aug 24. pii: WNL.0000000000006246.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Autoimmune Disorders is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: